Curative and palliative surgical treatment for cancers of the liver, pancreas, colon, rectum, gallbladder, and bile ducts — with robotic and minimally invasive options.
Hepatic resection, liver transplant (within Milan criteria), ablation (RFA/MWA), TACE. Multidisciplinary approach with oncology and interventional radiology.
Learn more →Whipple's procedure, distal pancreatectomy, borderline resectable assessment with neoadjuvant therapy. Robotic Whipple's for suitable cases.
Learn more →Right/left hemicolectomy, anterior resection, robotic low anterior resection for rectal cancer. TME technique for optimal oncological clearance.
Extended cholecystectomy with hepatic bed resection and lymphadenectomy. Management of incidental gallbladder cancers after laparoscopic cholecystectomy.
Hilar (Klatskin) and intrahepatic bile duct cancer surgery. Liver resection with biliary reconstruction. Liver transplant for selected hilar cases.
Subtotal and total gastrectomy with D2 lymphadenectomy. Robotic gastrectomy for eligible cases. Pre-operative staging with PET-CT and laparoscopy.
Every complex GI cancer case is reviewed at a multidisciplinary tumour board (MDT/MTB) involving surgical oncology, medical oncology, radiation oncology, radiology, and pathology before a treatment plan is finalised.
This ensures that the optimal sequence of surgery, chemotherapy, targeted therapy, and radiation is planned — not surgery first by default, but surgery at the right time with the right preparation.
